Nasopharyngeal carcinoma | RDL Research Database

Keywords

Nasopharyngeal carcinomaMedicineRadiation therapyOncologyDiseaseChemoradiotherapyPopulationEpidemiologyInternal medicineCarcinomaIncidence (geometry)ImmunologyEnvironmental health

Affiliated Institutions

Related Publications

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda , Laura Q.M. Chow , Elizabeth Claire Dees +9 more

Purpose Immune checkpoint inhibition has been demonstrated to be an effective anticancer strategy. Several lines of evidence support the study of immunotherapy in triple-negativ...

2016 Journal of Clinical Oncology 1427 citations

Cancer statistics, 2023

Rebecca L. Siegel , Kimberly D. Miller , Nikita Sandeep Wagle +1 more

Abstract Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based c...

2023 CA A Cancer Journal for Clinicians 15668 citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian , F. Stephen Hodi , Julie R. Brahmer +27 more

Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse...

2012 New England Journal of Medicine 12335 citations

Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival

Ahmedin Jemal , Limin X. Clegg , Elizabeth Ward +7 more

Abstract BACKGROUND The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Associat...

2004 Cancer 1140 citations

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi , Delvys Rodríguez‐Abreu , Shirish M. Gadgeel +26 more

In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...

2018 New England Journal of Medicine 6245 citations

Publication Info

Year: 2019
Type: review
Volume: 394
Issue: 10192
Pages: 64-80
Citations: 2829
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Nasopharyngeal carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2829

OpenAlex

Cite This

APA Style

                            
                                
                                    Yu‐Pei Chen, 
                                
                                    Anthony T.�C. Chan, 
                                
                                    Quynh‐Thu Le
                                
                                et al.
                            
                            (2019). 
                            Nasopharyngeal carcinoma. 
                            The Lancet
                            , 394
                            (10192)
                            , 64-80.
                            https://doi.org/10.1016/s0140-6736(19)30956-0
                        

Identifiers

DOI: 10.1016/s0140-6736(19)30956-0